BIGBEAR
PHARMACEUTICAL
Sotorasib covalently binds to the switch pocket of KRAS G12C mutant protein, specifically inhibits GTPase activity and blocks abnormal RAS signaling.
AuthenticGuaranteeFast DeliveryPrivacy Against the backdrop of increasing challenges in access to innovative drugs, the Laos Dabear version of Sotorasib, with its active ingredients highly ···【More】
Update: 03 Jun,2026Source: BigbearViews: 77
In recent years, the quietly emerged Lao Big Bear version of Sotorasib, an affordable alternative to this targeted therapy for refractory KRAS G12C mu···【More】
Update: 03 Jun,2026Source: BigbearViews: 76
The Laotian Bear version of Sotorasib, as the first generic version of the world's first approved KRAS G12C inhibitor original drug, is produced b···【More】
Update: 03 Jun,2026Source: BigbearViews: 77
Sotorasib (also known as LUMAKRAS) is an innovative targeted therapy for KRASG12C-mutant non-small cell lung cancer (NSCLC). Due to its unique pharmac···【More】
Update: 12 Mar,2026Source: BigbearViews: 112
Publicly available information shows that the price of the original brand-name drug Sotorasib is generally between $1,300 and $2,500, with the exact p···【More】
Update: 12 Mar,2026Source: BigbearViews: 119
Sotorasib is a targeted therapy for KRAS G12C-mutant non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, dosage, p···【More】
Update: 25 Feb,2026Source: BigbearViews: 105
Sotorasib (generic name: Sotorasib) is a prescription drug targeting a specific gene mutation (KRAS G12C) in non-small cell lung cancer. Its price is ···【More】
Update: 25 Feb,2026Source: BigbearViews: 104
The price of Sotorasib varies significantly depending on the region, purchase channel, and dosage. The specific price should be confirmed with the hos···【More】
Update: 25 Feb,2026Source: BigbearViews: 105
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
